Literature DB >> 17502668

Interaction between respiratory syncytial virus and glycosaminoglycans, including heparan sulfate.

Louay K Hallak1, Steven A Kwilas, Mark E Peeples.   

Abstract

Glycosaminoglycans (GAGs), including heparan sulfate (HS), are expressed on the surface of nearly all cells, linked to transmembrane proteins. These GAGs are sulfated to varying extents, lending a negative charge, and are used by a large number of viruses to initiate infection of immortalized cell lines. Here we describe the rationale and methods for analyzing GAG usage by one such virus, respiratory syncytial virus (RSV). The protocols presented allow the determination of which GAG(s) is employed by the virus, which GAG modification(s) is important, and whether the important GAG is on the cell or on the virus. We also discuss the finding that many viruses are selected for GAG usage during passage in culture and present a method for rapidly determining whether GAG usage is characteristic of a wild virus or is limited to laboratory-adapted virus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502668     DOI: 10.1007/978-1-59745-393-6_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

1.  The comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics.

Authors:  Lydia Tan; Frank E J Coenjaerts; Lieselot Houspie; Marco C Viveen; Grada M van Bleek; Emmanuel J H J Wiertz; Darren P Martin; Philippe Lemey
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

2.  Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.

Authors:  Xuancheng Guo; Taixiang Liu; Hengfei Shi; Jingjing Wang; Ping Ji; Hongwei Wang; Yayi Hou; Ren Xiang Tan; Erguang Li
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

3.  Filoviruses utilize glycosaminoglycans for their attachment to target cells.

Authors:  Beatriz Salvador; Nicole R Sexton; Ricardo Carrion; Jerritt Nunneley; Jean L Patterson; Imke Steffen; Kai Lu; Marcus O Muench; David Lembo; Graham Simmons
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

4.  Identification of nucleolin as a cellular receptor for human respiratory syncytial virus.

Authors:  Farnoosh Tayyari; David Marchant; Theo J Moraes; Wenming Duan; Peter Mastrangelo; Richard G Hegele
Journal:  Nat Med       Date:  2011-08-14       Impact factor: 53.440

5.  Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells.

Authors:  Homero San-Juan-Vergara; Viviana Sampayo-Escobar; Niradiz Reyes; Byeong Cha; Lisandro Pacheco-Lugo; Terianne Wong; Mark E Peeples; Peter L Collins; Maria Eugenia Castaño; Shyam S Mohapatra
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

6.  The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation.

Authors:  D Tien Nguyen; Lot de Witte; Martin Ludlow; Selma Yüksel; Karl-Heinz Wiesmüller; Teunis B H Geijtenbeek; Albert D M E Osterhaus; Rik L de Swart
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

7.  Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection.

Authors:  Sutthiwan Thammawat; Tania A Sadlon; Peter G Hallsworth; David L Gordon
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

Review 8.  Structure and function of respiratory syncytial virus surface glycoproteins.

Authors:  Jason S McLellan; William C Ray; Mark E Peeples
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

9.  Isolation of a native osteoblast matrix with a specific affinity for BMP2.

Authors:  Martin Grünert; Christian Dombrowski; Murali Sadasivam; Kerry Manton; Simon M Cool; Victor Nurcombe
Journal:  J Mol Histol       Date:  2007-08-08       Impact factor: 2.611

10.  Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes.

Authors:  Qing Shi; Jieyun Jiang; Guangxiang Luo
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.